Ontology highlight
ABSTRACT: Introduction
Developing effective therapeutics for Alzheimer's Disease (AD) requires a better understanding of the molecular drivers of the disease. Our previous work nominated DLGAP2 as a modifier of age-related cognitive decline and risk for AD. We tested the hypothesis that overexpression of DLGAP2 in the hippocampus would protect against cognitive and synaptic deficits in a susceptible F1 5XFAD model.Methods
DLGAP2 was overexpressed in the hippocampus of F1 hybrid 5XFAD and nontransgenic littermates using a viral approach. Cognitive function, electrophysiological properties, and dendritic spine morphology were assessed at 6 and 14 months of age.Results
DLGAP2 overexpression impaired synaptic plasticity and exacerbated AD-related memory defic
SUBMITTER: Ouellette A
PROVIDER: S-EPMC12132555 | biostudies-literature | 2025 May
REPOSITORIES: biostudies-literature